SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-19-007995
Filing Date
2019-05-08
Accepted
2019-05-08 06:43:10
Documents
6
Period of Report
2019-05-07
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k050719_delmarpharma.htm 8-K 33781
2 CERTIFICATE OF CHANGE OF DELMAR PHARMACEUTICALS, INC., DATED MAY 7, 2019 AND EFF f8k050719ex3-1_delmar.htm EX-3.1 1988
3 PRESS RELEASE DATED MAY 7, 2019, ISSUED BY THE COMPANY f8k050719ex99-1_delmar.htm EX-99.1 7524
4 GRAPHIC slide_1.jpg GRAPHIC 176750
5 GRAPHIC slide_2.jpg GRAPHIC 222111
6 GRAPHIC image_001.jpg GRAPHIC 9674
  Complete submission text file 0001213900-19-007995.txt   607556
Mailing Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (604) 629-5989
DelMar Pharmaceuticals, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-37823 | Film No.: 19805081
SIC: 2834 Pharmaceutical Preparations